immunotherapy is a promising cancer therapeutic strategy. however, the “cold” tumor immune microenvironment (time), characterized by insufficient immune cell infiltration and immunosuppressive status, limits the efficacy of immunotherapy. tumor vascular abnormalities due to defective pericyte coverage are gradually recognized as a profound determinant in “cold” time establishment by hindering immune cell trafficking. recently, several vascular normalization strategies by improving pericyte coverage have been reported, whereas have unsatisfactory efficacy and high rates of resistance. herein, a combinatorial strategy to induce tumor vasculature-targeted pericyte recruitment and zinc ion-mediated immune activation with a platelet-derived growth factor b (pdgfb)-loaded, cyclo (arg-gly-asp-d-phe-lys)-modified zeolitic imidazolate framework 8 (pdgfb@zif8-rgd) nanoplatform is proposed.
